These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11814786)

  • 21. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption.
    Altmann SW; Davis HR; Yao X; Laverty M; Compton DS; Zhu LJ; Crona JH; Caplen MA; Hoos LM; Tetzloff G; Priestley T; Burnett DA; Strader CD; Graziano MP
    Biochim Biophys Acta; 2002 Jan; 1580(1):77-93. PubMed ID: 11923102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of novel amide amino-β-lactam derivatives as cholesterol absorption inhibitors.
    Dražić T; Sachdev V; Leopold C; Patankar JV; Malnar M; Hećimović S; Levak-Frank S; Habuš I; Kratky D
    Bioorg Med Chem; 2015 May; 23(10):2353-9. PubMed ID: 25882530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane.
    Kramer W; Girbig F; Corsiero D; Pfenninger A; Frick W; Jähne G; Rhein M; Wendler W; Lottspeich F; Hochleitner EO; Orsó E; Schmitz G
    J Biol Chem; 2005 Jan; 280(2):1306-20. PubMed ID: 15494415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
    Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
    Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total synthesis of ezetimibe, a cholesterol absorption inhibitor.
    Śnieżek M; Stecko S; Panfil I; Furman B; Chmielewski M
    J Org Chem; 2013 Jul; 78(14):7048-57. PubMed ID: 23763523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.
    Clader JW; Burnett DA; Caplen MA; Domalski MS; Dugar S; Vaccaro W; Sher R; Browne ME; Zhao H; Burrier RE; Salisbury B; Davis HR
    J Med Chem; 1996 Sep; 39(19):3684-93. PubMed ID: 8809157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
    Salisbury BG; Davis HR; Burrier RE; Burnett DA; Bowkow G; Caplen MA; Clemmons AL; Compton DS; Hoos LM; McGregor DG
    Atherosclerosis; 1995 May; 115(1):45-63. PubMed ID: 7669087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters.
    Bandyopadhyay S; Katare OP; Singh B
    Expert Opin Drug Deliv; 2014 Apr; 11(4):479-92. PubMed ID: 24386966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rabbit small intestine does not contain an annexin II/caveolin 1 complex as a target for 2-azetidinone cholesterol absorption inhibitors.
    Kramer W; Corsiero D; Girbig F; Jähne G
    Biochim Biophys Acta; 2006 Jan; 1758(1):45-54. PubMed ID: 16458850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663.
    van Heek M; Farley C; Compton DS; Hoos L; Alton KB; Sybertz EJ; Davis HR
    Br J Pharmacol; 2000 Apr; 129(8):1748-54. PubMed ID: 10780982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 32. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fresh from the pipeline. Ezetimibe.
    Earl J; Kirkpatrick P
    Nat Rev Drug Discov; 2003 Feb; 2(2):97-8. PubMed ID: 12572539
    [No Abstract]   [Full Text] [Related]  

  • 34. 2-Azetidinone derivatives: design, synthesis and evaluation of cholesterol absorption inhibitors.
    Wang Y; Zhang H; Huang W; Kong J; Zhou J; Zhang B
    Eur J Med Chem; 2009 Apr; 44(4):1638-43. PubMed ID: 18990470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy.
    Howell KL; DeVita RJ; Garcia-Calvo M; Meurer RD; Lisnock J; Bull HG; McMasters DR; McCann ME; Mills SG
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6929-32. PubMed ID: 21030254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapies targeting exogenous cholesterol uptake: new insights and controversies.
    Davidson MH
    Curr Atheroscler Rep; 2011 Feb; 13(1):95-100. PubMed ID: 21188557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Evaluation of 2-Azetidinone and 1H-Pyrrole-2,5-dione Derivatives as Cholesterol Absorption Inhibitors for Reducing Inflammation Response and Oxidative Stress.
    Xia Y; Zhu L; Yuan X; Wang Y
    Chem Biodivers; 2019 Feb; 16(2):e1800189. PubMed ID: 30230227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.
    Ge L; Wang J; Qi W; Miao HH; Cao J; Qu YX; Li BL; Song BL
    Cell Metab; 2008 Jun; 7(6):508-19. PubMed ID: 18522832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.